132 related articles for article (PubMed ID: 16883623)
21. Medical decision-making abilities in older adults with chronic partial epilepsy.
Bambara JK; Griffith HR; Martin RC; Faught E; Wadley VG; Marson DC
Epilepsy Behav; 2007 Feb; 10(1):63-8. PubMed ID: 17088106
[TBL] [Abstract][Full Text] [Related]
22. Capacity to consent to research participation in adults with malignant glioma.
Marson DC; Martin RC; Triebel KL; Nabors LB
J Clin Oncol; 2010 Aug; 28(24):3844-50. PubMed ID: 20644102
[TBL] [Abstract][Full Text] [Related]
23. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
24. Medical decision-making capacity and its cognitive predictors in progressive MS: Preliminary evidence.
Gerstenecker A; Lowry K; Myers T; Bashir K; Triebel KL; Martin RC; Marson DC
J Neurol Sci; 2017 Sep; 380():38-43. PubMed ID: 28870585
[TBL] [Abstract][Full Text] [Related]
25. The ability of persons with Alzheimer disease (AD) to make a decision about taking an AD treatment.
Karlawish JH; Casarett DJ; James BD; Xie SX; Kim SY
Neurology; 2005 May; 64(9):1514-9. PubMed ID: 15883310
[TBL] [Abstract][Full Text] [Related]
26. Medical decision-making in neurodegenerative disease: mild AD and PD with cognitive impairment.
Griffith HR; Dymek MP; Atchison P; Harrell L; Marson DC
Neurology; 2005 Aug; 65(3):483-5. PubMed ID: 16087924
[TBL] [Abstract][Full Text] [Related]
27. Quantitative EEG in progressing vs stable mild cognitive impairment (MCI): results of a 1-year follow-up study.
Luckhaus C; Grass-Kapanke B; Blaeser I; Ihl R; Supprian T; Winterer G; Zielasek J; Brinkmeyer J
Int J Geriatr Psychiatry; 2008 Nov; 23(11):1148-55. PubMed ID: 18537220
[TBL] [Abstract][Full Text] [Related]
28. Impairment of medical decisional capacity in relation to Karnofsky Performance Status in adults with malignant brain tumor.
Martin RC; Gerstenecker A; Nabors LB; Marson DC; Triebel KL
Neurooncol Pract; 2015 Mar; 2(1):13-19. PubMed ID: 26034637
[TBL] [Abstract][Full Text] [Related]
29. Psychometric Properties of a Decisional Capacity Screening Tool for Individuals Contemplating Participation in Alzheimer's Disease Research.
Seaman JB; Terhorst L; Gentry A; Hunsaker A; Parker LS; Lingler JH
J Alzheimers Dis; 2015; 46(1):1-9. PubMed ID: 25765917
[TBL] [Abstract][Full Text] [Related]
30. Affective symptoms as predictors of Alzheimer's disease in subjects with mild cognitive impairment: a 10-year follow-up study.
Ramakers IH; Visser PJ; Aalten P; Kester A; Jolles J; Verhey FR
Psychol Med; 2010 Jul; 40(7):1193-201. PubMed ID: 19903364
[TBL] [Abstract][Full Text] [Related]
31. Assessing the competence of persons with Alzheimer's disease in providing informed consent for participation in research.
Kim SY; Caine ED; Currier GW; Leibovici A; Ryan JM
Am J Psychiatry; 2001 May; 158(5):712-7. PubMed ID: 11329391
[TBL] [Abstract][Full Text] [Related]
32. Structured assessment of mental capacity to make financial decisions in Chinese older persons with mild cognitive impairment and mild Alzheimer disease.
Lui VW; Lam LC; Chau RC; Fung AW; Wong BM; Leung GT; Leung KF; Chiu HF; Karlawish JH; Appelbaum PS
J Geriatr Psychiatry Neurol; 2013 Jun; 26(2):69-77. PubMed ID: 23504307
[TBL] [Abstract][Full Text] [Related]
33. Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration.
Rozzini L; Chilovi BV; Conti M; Bertoletti E; Delrio I; Trabucchi M; Padovani A
Int J Geriatr Psychiatry; 2007 Dec; 22(12):1217-22. PubMed ID: 17562522
[TBL] [Abstract][Full Text] [Related]
34. Clinical interview assessment of financial capacity in older adults with mild cognitive impairment and Alzheimer's disease.
Marson DC; Martin RC; Wadley V; Griffith HR; Snyder S; Goode PS; Kinney FC; Nicholas AP; Steele T; Anderson B; Zamrini E; Raman R; Bartolucci A; Harrell LE
J Am Geriatr Soc; 2009 May; 57(5):806-14. PubMed ID: 19453308
[TBL] [Abstract][Full Text] [Related]
35. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment.
Tabert MH; Manly JJ; Liu X; Pelton GH; Rosenblum S; Jacobs M; Zamora D; Goodkind M; Bell K; Stern Y; Devanand DP
Arch Gen Psychiatry; 2006 Aug; 63(8):916-24. PubMed ID: 16894068
[TBL] [Abstract][Full Text] [Related]
36. Decisional capacity to consent to treatment and research in patients affected by Mild Cognitive Impairment. A systematic review and meta-analysis.
Parmigiani G; Del Casale A; Mandarelli G; Barchielli B; Kotzalidis GD; D'Antonio F; Di Vita A; de Lena C; Ferracuti S
Int Psychogeriatr; 2022 Jun; 34(6):529-542. PubMed ID: 33583459
[TBL] [Abstract][Full Text] [Related]
37. Capacity of patients with brain metastases to make treatment decisions.
Triebel KL; Gerstenecker A; Meneses K; Fiveash JB; Meyers CA; Cutter G; Marson DC; Martin RC; Eakin A; Watts O; Nabors LB
Psychooncology; 2015 Nov; 24(11):1448-55. PubMed ID: 25613039
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the slopes of cognitive impairment and disability in Alzheimer's disease (AD) patients treated with acetylcholinesterase inhibitors (AChEl).
Campanozzi MD; Casali E; Neviani F; Martini E; Neri M
Arch Gerontol Geriatr; 2007; 44 Suppl 1():91-6. PubMed ID: 17317439
[TBL] [Abstract][Full Text] [Related]
39. Neuropsychologic predictors of competency in Alzheimer's disease using a rational reasons legal standard.
Marson DC; Cody HA; Ingram KK; Harrell LE
Arch Neurol; 1995 Oct; 52(10):955-9. PubMed ID: 7575222
[TBL] [Abstract][Full Text] [Related]
40. Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up.
Devanand DP; Michaels-Marston KS; Liu X; Pelton GH; Padilla M; Marder K; Bell K; Stern Y; Mayeux R
Am J Psychiatry; 2000 Sep; 157(9):1399-405. PubMed ID: 10964854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
